Kanabo Group Plc (LON:KNB)

Market Cap	1.42M -86.8%
Revenue (ttm)	1.14M +40.2%
Net Income	-8.18M
EPS	-0.01
Shares Out	632.43M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	414,525
Average Volume	604,161
Open	0.3000
Previous Close	0.3000
Day's Range	0.2000 - 0.3300
52-Week Range	0.1500 - 2.0000
Beta	2.72
RSI	26.55
Earnings Date	n/a

About Kanabo Group

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2016
• Employees: 20
• Stock Exchange: London Stock Exchange
• Ticker Symbol: KNB

Financial Performance

In 2023, Kanabo Group's revenue was 895,000, an increase of 48.42% compared to the previous year's 603,000. Losses were -7.99 million, 16.3% more than in 2022.